0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Analysis and Commentary Guest User 4/24/20 Analysis and Commentary Guest User 4/24/20

How Can Congress Agree to Appropriations for FY 21?

Read More
Analysis and Commentary Guest User 4/17/20 Analysis and Commentary Guest User 4/17/20

The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply

Read More
Advocacy at a Glance Guest User 4/17/20 Advocacy at a Glance Guest User 4/17/20

Congress Out Until at Least May 4; Not Clear How Work Will Be Done

Read More
Analysis and Commentary Guest User 4/3/20 Analysis and Commentary Guest User 4/3/20

Advocating for a Responsibility-based "Ask"

Read More
Advocacy at a Glance Guest User 4/3/20 Advocacy at a Glance Guest User 4/3/20

Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA

Read More
Analysis and Commentary Guest User 3/27/20 Analysis and Commentary Guest User 3/27/20

Coronavirus, Pandemic Preparedness, and Beyond

Read More
Advocacy at a Glance Guest User 3/27/20 Advocacy at a Glance Guest User 3/27/20

FDA Gains $80 Million in Third Pandemic Relief Bill

Read More
Analysis and Commentary Guest User 3/19/20 Analysis and Commentary Guest User 3/19/20

Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation

Read More
Advocacy at a Glance Guest User 3/20/20 Advocacy at a Glance Guest User 3/20/20

Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides

Read More
Analysis and Commentary Guest User 3/13/20 Analysis and Commentary Guest User 3/13/20

"Cures," Coronavirus, NDD, and Other Issues for FY 21

Read More
Advocacy at a Glance Guest User 3/13/20 Advocacy at a Glance Guest User 3/13/20

The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely

Read More
Analysis and Commentary Guest User 3/5/20 Analysis and Commentary Guest User 3/5/20

Additional funding for FDA; more Qs and As

Read More
Advocacy at a Glance Guest User 3/6/20 Advocacy at a Glance Guest User 3/6/20

Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate

Read More
Analysis and Commentary Guest User 2/27/20 Analysis and Commentary Guest User 2/27/20

More Qs and As About the FY 21 Appropriation Process

Read More
Advocacy at a Glance Guest User 2/28/20 Advocacy at a Glance Guest User 2/28/20

Coronavirus Supplemental Likely to Be Considered Quickly

Read More
Analysis and Commentary Guest User 2/21/20 Analysis and Commentary Guest User 2/21/20

TMAP: Planning for Efficient, Effective Data Management at FDA

Read More
Advocacy at a Glance Guest User 2/21/20 Advocacy at a Glance Guest User 2/21/20

Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation

Read More
Guest User 2/20/20 Guest User 2/20/20

Join Us for Our Annual Hill Day on March 18!

Read More
Guest User 2/19/20 Guest User 2/19/20

Alliance for a Stronger FDA Announces New Officers for 2020

Read More
Analysis and Commentary Guest User 2/14/20 Analysis and Commentary Guest User 2/14/20

The Alliance's Assessment of the President's FY 21 Budget Request

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.